Purchases and Sales Made in Q4 2021 in Atea Pharmaceuticals, Inc. (AVIR)
This table provides information about the institutional ownership of Atea Pharmaceuticals, Inc. (AVIR) during Q4 2021. The information is specifically focused on institutions that hold shares of Atea Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2022
Q4 2021
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-118KClosed |
$902K - $5.24M
|
0
$0
|
|
Feb 02, 2022
Q4 2021
|
Emerald Mutual Fund Advisers Trust
|
SELL
|
- |
-124KClosed |
$950K - $5.52M
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Canada Pension Plan Investment Board
Toronto Ontario, A6 |
SELL
|
- |
-138KClosed |
$1.06M - $6.15M
|
0
$0
|
|
Feb 16, 2022
Q4 2021
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-150KClosed |
$1.15M - $6.69M
|
0
$0
|
|
Feb 02, 2022
Q4 2021
|
Banque Pictet & Cie Sa
|
SELL
|
- |
-150K- 34.2% |
$1.15M - $6.69M
|
289K
$981K
|
|
Feb 14, 2022
Q4 2021
|
Omega Fund Management, LLC
Boston, MA |
SELL
|
- |
-165KClosed |
$1.26M - $7.34M
|
0
$0
|
|
Feb 02, 2022
Q4 2021
|
Emerald Advisers, LLC
|
SELL
|
- |
-174KClosed |
$1.33M - $7.76M
|
0
$0
|
|
Jan 19, 2022
Q4 2021
|
Frontier Capital Management CO LLC
|
SELL
|
- |
-179KClosed |
$1.38M - $8M
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-230K- 81.63% |
$1.76M - $10.3M
|
51.8K
$176K
|
|
Feb 14, 2022
Q4 2021
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-284K- 89.52% |
$2.18M - $12.7M
|
33.3K
$113K
|
|
Feb 14, 2022
Q4 2021
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-303KClosed |
$2.32M - $13.5M
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Oracle Investment Management Inc
Greenwich, CT |
SELL
|
- |
-309KClosed |
$2.37M - $13.8M
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-332KClosed |
$2.55M - $14.8M
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-335K- 98.54% |
$2.57M - $14.9M
|
4.95K
$16.8K
|
|
Feb 14, 2022
Q4 2021
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-422KClosed |
$3.24M - $18.8M
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-434K- 60.8% |
$3.33M - $19.3M
|
280K
$951K
|
|
Feb 14, 2022
Q4 2021
|
Rock Springs Capital Management LP
Baltimore, MD |
SELL
|
- |
-750KClosed |
$5.75M - $33.5M
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.08M- 72.4% |
$8.31M - $48.3M
|
413K
$1.4M
|
|
Feb 14, 2022
Q4 2021
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
SELL
|
- |
-1.21M- 32.82% |
$9.31M - $54.1M
|
2.49M
$8.45M
|
|
Feb 09, 2022
Q4 2021
|
Aju Ib Investment Co., Ltd.
Seoul, M5 |
SELL
|
- |
-1.64MClosed |
$12.6M - $73M
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Viking Global Investors LP
|
SELL
|
- |
-1.66MClosed |
$12.7M - $73.8M
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-2.26MClosed |
$17.3M - $101M
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-3.25M- 65.93% |
$24.9M - $145M
|
1.68M
$5.71M
|
|
Feb 14, 2022
Q4 2021
|
Ra Capital Management, L.P.
Boston, MA |
SELL
|
- |
-5.43MClosed |
$41.6M - $242M
|
0
$0
|